Show simple item record

dc.identifier.urihttp://hdl.handle.net/11401/78349
dc.description.sponsorshipThis work is sponsored by the Stony Brook University Graduate School in compliance with the requirements for completion of degreeen_US
dc.formatMonograph
dc.format.mediumElectronic Resourceen_US
dc.format.mimetypeApplication/PDFen_US
dc.language.isoen_US
dc.typeThesis
dcterms.abstractDespite recent advances in the detection and treatment of cancer, it remains the second most common cause of death in the United States, second only to heart disease. It is estimated that half of all men and a third of all women in America will develop cancer in their lifetimes. Traditional chemotherapy is predicated on the idea that rapidly dividing cells (such as tumor cells in nascent stages of cancer development), can be targeted preferentially by chemotherapeutic agents. Commonly, plant alkaloids, such as vincristine and paclitaxel, have been utilized to induce apoptosis in cancer cells. Next generation taxoid SB-T-1214, a taxoid superior to paclitaxel, was synthesized. Molecular dynamics simulations of the further improved third generation taxoids SB-T-1214-05 and SB-T-1214-06 were performed to investigate the discrepancy in their potencies against certain cancer cell lines. Another natural product, Combretastatin A-4 (CA4) is known to act as a vascular disrupting agent (VDA) by increasing the permeability of tumor vasculature, causing leakage of plasma proteins and reduction of vessel diameter. The reduction in diameter causes high interstitial fluid pressure and results in red blood cell stacking, increasing the viscosity of the blood and effectively choking the tumor of nutrients, resulting in tumor necrosis. In this research, novel fluorine-containing CA4 analogs were designed following virtual screening using DOCK 6.7 and use of docking software with Glide and Autodock Vina. The analogs were synthesized for evaluation against different cancer cell lines.
dcterms.available2018-07-09T13:54:32Z
dcterms.contributorDrueckhammer, Dale G.en_US
dcterms.contributorOjima, Iwao.en_US
dcterms.contributorGoroff, Dancy S.en_US
dcterms.creatorMaffucci, Katherine
dcterms.dateAccepted2018-07-09T13:54:32Z
dcterms.dateSubmitted2018-07-09T13:54:32Z
dcterms.descriptionDepartment of Chemistry.en_US
dcterms.extent121 pg.en_US
dcterms.formatMonograph
dcterms.identifierhttp://hdl.handle.net/11401/78349
dcterms.identifierMaffucci_grad.sunysb_0771M_13464.pdfen_US
dcterms.issued2017-08-01
dcterms.languageen_US
dcterms.provenanceSubmitted by Jason Torre (fjason.torre@stonybrook.edu) on 2018-07-09T13:54:32Z No. of bitstreams: 1 Maffucci_grad.sunysb_0771M_13464.pdf: 5586014 bytes, checksum: ddd1c805684fc31d319c36694f3138c6 (MD5)en
dcterms.provenanceMade available in DSpace on 2018-07-09T13:54:32Z (GMT). No. of bitstreams: 1 Maffucci_grad.sunysb_0771M_13464.pdf: 5586014 bytes, checksum: ddd1c805684fc31d319c36694f3138c6 (MD5) Previous issue date: 2017-08-01en
dcterms.subjectChemistry, Organic
dcterms.subjectCytology
dcterms.titleComputational Design and Synthesis of Novel Fluorine-Containing Combretastatin A-4 Analogs and Synthesis of SB-T-1214
dcterms.typeThesis


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record